News About: Pharm. Affairs
Which took the top among imported drugs?
Which do you think was the most imported OTC drug into Korea last year?
According to the analysis result of the 2015’s OTC drug imports revealed by the Korea Pharmaceutical Traders Association, pharmaceutical product...
Revolade earns insurance benefit from 1st
The drug benefit standards for 4 new drugs, such as a thrombocytopenia treatment, Revolade, will open from the 1st of the next month. On the same day, the benefit standards for painkillers in the combination with Lyri...
‘Viread’ positioned the top among imported products while anticancer and vaccines in top ranking
The reputation of hepatitis B treatments was still solid.
This is because ‘Viread(sold by Gilead and Yuhan Corporation)’ and ‘Baraclude(sold by BMS Korea, and sold by Green Cross from September last year)’ took the ...
KRW 58 trillion medical expenses for health insurance benefits in 2015
The Health Insurance Review & Assessment Service(Chief Director Myung-sae Sohn) announced the total medical expenses deliberated with the deliberation standard were KRW 66 trillion(increased by 6.46%) in 2015.
When i...
Psychotropic drugs records the most for generic development in 2015
The Ministry of Food and Drug Safety(Minister Seung-hee Kim) announced there were the total 201 cases of bioequivalence test approval to acquire generic product approvals in 2015, increased approximately by 30% compar...
‘Aronamin, Belviq and Gugu’ to rush as OTC and non-benefit drugs
In 2015, OTC drugs and pharmaceutical products with no insurance benefit brought sensations led by Aronamin, Belviq, Champix and Gugu.
According to the Daily Pharm’s analysis result of the 2015’s major product sales ...
“Statement about permission for Korean medicine doctors to use 5 types of medical device was inappropriate”
When it came to a statement of a director of the Ministry of Health and Welfare to allow Korean medicine doctors to use a part of modern medical devices, the medical industry got outraged.
At the policy debate on the...
MFDS starts to make ‘Korean Orange Book’ containing generic approval information
The government attracted attention as deciding to make the ‘Korean Orange Book’ containing details about domestic approvals for generic products.
From this March, bioequivalent test results and details are obligated ...
Gardasil and Servarix on a log bridge
As expected, both ‘Gardasil’ and ‘Servarix’ were selected as vaccines for the National Immunization Program for cervical cancer, but the real competition has not been started. This is because how to calculate prices o...
The impact of Hanmi Flu on Tamiflu
Tamiflu, which has been the only treatment for influenza A & B, seems to be significantly influenced by Hanmi Flu that will be launched on the 26th.
The pharmaceutical distribution expects Tamiflu, which has enjoyed ...
